A Phase 1 Study to Evaluate the Safety and Pharmacokinetics of Ezerosu Tab

NCT06225635 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Hyperlipidemias

Interventions

DRUG: Ezerosu(monolayer tablet)
DRUG: Ezerosu(double layer tablet)

Sponsor

Shin Poong Pharmaceutical Co. Ltd.